Single ingredient codeine medicines are set to be downscheduled across the Tasman New Zealand’s Medicines Classification Committee (MCC) has decided to downschedule single ingredient codeine medicines and upschedule all codeine combination medicines to prescription only. Kiwis have until 31 January 2020 to implement the changes. The MCC had been considering reclassifying codeine for some time,
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.